Prevalence of Childhood Attention-Deficit/Hyperactivity Disorder (ADHD) in Methamphetamine Dependence: A Descriptive Study

AUTHORS

Vahid Farnia 1 , Seyyed Bagher Mousavi 1 , Faezeh Tatari 1 , Safora Salemi ORCID 1 , * , Sanobar Golshani 1 , Mostafa Alikhani 1 , Shima Heydari 2 , Sara Hookari 1

1 Department of Psychiatry, Substance Abuse Prevention Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran

2 Department of Psychiatry, Kermanshah University of Medical Sciences, Kermanshah, Iran

How to Cite: Farnia V, Mousavi S B, Tatari F, Salemi S, Golshani S, et al. Prevalence of Childhood Attention-Deficit/Hyperactivity Disorder (ADHD) in Methamphetamine Dependence: A Descriptive Study, Iran J Psychiatry Behav Sci. 2018 ; 12(4):e61329. doi: 10.5812/ijpbs.61329.

ARTICLE INFORMATION

Iranian Journal of Psychiatry and Behavioral Sciences: 12 (4); e61329
Published Online: July 21, 2018
Article Type: Original Article
Received: September 16, 2017
Revised: February 11, 2018
Accepted: May 11, 2018
Crossmark
Crossmark
CHECKING
READ FULL TEXT

Abstract

Background: The high comorbidity of psychiatric disorders and substance dependence has been reported in children clinical and epidemiological as a study.

Objectives: The aim of this study was to determine the prevalence of childhood attention-deficit/hyperactivity disorder (ADHD) among methamphetamine dependence.

Methods: This study was a descriptive cross - sectional study that has been done in 2015 - 2016. The study population consisted of individuals referred with methamphetamine dependence to Kermanshah Farabi hospital. Among them, 960 patients were chosen through access selection to collect data the epidemiological characteristics questionnaire and the Wender Utah rating scale for ADHD children were used. Data were analyzed through SPSS 18 software descriptive statistical methods and chi-square test.

Results: The prevalence of childhood ADHD was 29.9%. In the study population 155 patients (16.17) had hyperactivity disorder, 402 patients (41.9%) had attention deficit disorder, and 141 patients (14.7%) had hyperactivity and attention deficit disorders simultaneously. In addition, data analysis reveals the meaningful relationship between childhood ADHD and gender marital status education as well as age range (P < 0.001). For participants, job and age of first methamphetamine use, which P = 0.484 and P = 0.453, respectively, no meaningful relationship was found to ADHD.

Conclusions: Behavioral disorders, especially ADHD, can make a background for methamphetamine dependence tendency. ADHD treatments may prevent this disposition towards methamphetamine dependence.

1. Background

The pattern of substance abuse has changed considerably in recent years and has changed from opiate to opioid with newer forms and artificial substances such as methamphetamine (1-4). Nowadays, among addiction types, addiction to methamphetamine is highlighted and one of the basic problems has changed (5-7).

Methamphetamine is a phenyl ethylamine compound and is a psychoactive substance that acts on the various regions of the brain leading to dopamine disorder and has severe effects on the sympathetic system. The direct harm that can be caused by use of methamphetamine in the person and the accompanying psychiatric symptoms can lead to significant disability in people (8-10).

Researchers have suggested that some drug abusers tend to use drugs or alcohol to mitigate their unpleasant emotional states (11). According to research reports, the relationship between the psychological state and drug abuse has been confirmed in most studies (12). The results of the current study show that both attention deficit hyperactivity disorder (ADHD) and drug abuse are the most common disorders in the general population and most often both appear simultaneously in one person. In addition, there is a close relationship between attention deficit hyperactivity disorder (ADHD) and drug use disorders (13). Attention deficit hyperactivity disorder (ADHD) is a kind of behavior that appears in ones childhood and progressively evolves with an inappropriate amount of lack of attention, impulsiveness, and aggressiveness (14). The prevalence of this disorder in children is 3% to 10%, of which 1/3 to 2/3 of them have a problem in adulthood and is estimated to be prevalent in the adult population from 1% to 6%. Contrary to the past, today it is believed that symptoms of this disorder continue to occur after puberty (15). This disorder causes many problems for affected people and affects the social, educational, and emotional development of affected people (16). On the other hand, this disorder increases the risk of substance abuse, delinquency, imprisonment, job failure, divorce, and marital problems (17). Prevalence of attention deficit hyperactivity disorder (ADHD) is estimated as 0.2% - 20% in primary school students (18); the prevalence of substance abuse disorders in teenagers who have had ADHD was significantly higher than teenagers that have not had ADHD (41% vs. 0.16); furthermore, the ratio of adults with drug abuse disorders who had ADHD in their childhood to a healthy adult is 0.52 vs. 0.27 (19). Hence, attention deficit hyperactivity disorder (ADHD) is not considered a childhood disorder and people with this disorder have encountered some consequences such as academic failure, occupational problems, and more risk behaviors such as drug use at a cognitive, behavioral, and emotional level (20).

Studies have been conducted on the co-occurrence of psychiatric disorders with materials such as cocaine. However, no similar study has been done to comprehensively assess the prevalence of attention deficit hyperactivity disorder (ADHD) and its clinical and demographic characteristics in methamphetamine dependence. Of course, limited studies have been generally conducted on the prevalence of comorbidities in psychiatric disorders such as mood disorders, psychotic disorders, and anxiety disorders. The assessment of this issue is important in such a way that comorbidities in psychiatric disorders will lead to undesirable effects on prognosis, response to treatment, and discontinuation of methamphetamine, and will reduce the individual’s adherence to treatment. The studies show that those patients who have mental health have better prognosis in the treatment process than those who have psychiatric problems. Therefore, the accurate diagnosis and description of abnormalities is the first step in the successful treatment of the drug abuser Therefore, the present study was conducted to determine the prevalence of attention deficit hyperactivity disorder (ADHD) in methamphetamine dependence.

2. Objectives

Given the significant prevalence of childhood ADHD in methamphetamine dependents and the continuation of this disorder until adulthood, also the likelihood of its impact on treatment outcomes, the diagnosis of this disorder is important in these patients.

3. Patients and Methods

This analytical cross - sectional study took nearly one year (2015-2016). The population of this study included all methamphetamine dependence individuals that referred to the Farabi Hospital in the city of Kermanshah, of them, 960 people were selected accessibly. The criteria to enter the study are: (a) aged between 15 and 75, and (b) taking methamphetamine in the form of drug dependency or drug abuse. The criterion for determining the dependence of methamphetamine was hospitalization and treatment due to methamphetamine use. The inclusion criteria for this study included (a) psychotic disorders (diagnosis of psychotic symptoms was done by a psychiatrist and based on clinical interview), (b) mental retardation, (c) signs and symptoms of toxicity and delirium due to methamphetamine, (d) co-dependency on several substances, and (e) those who have not been taking substance for more than one month.

3.1. Tools

3.1.1. Wender - Utah Test

In 1993, in the U.S., at Utah University, Wender et al., provided a questionnaire by which an adult can assess their condition in terms of attention deficit hyperactivity disorder (ADHD) during childhood. This questionnaire included 61 items in a Likert scale (rarely to very high). The studies that are conducted in various countries showed that the Wender - Utah test had a good validity and reliability and was suitable tool for examining attention deficit hyperactivity disorder in childhood. This test has been translated to different languages up to now (21). In Iran, this test is translated by Sarami Foroushani and its validity and reliability is examined by him (2000). The coefficient of test validity in Sarami Foroushani is reported 0.96 in the research. Then, in the stage of determining structural validity, the average score of the test was estimated as 25.62 in patients and average score of the test was estimated 8 in healthy subjects. There is significant difference between average scores of two groups in the test. In other words, this test has a suitable criterion validity (22).

3.1.2. Demographic Information Questionnaire

A demographic questionnaire was used to measure individual, social, and economic indicators.

3.2. Ethical Considerations

This study has been approved by the Ethics Committee of Kermanshah University of Medical Sciences, Kermanshah, Iran (Ethical code is 143).

The complete and clear information on the purpose of the research was given to all participants and they were assured that the questionnaires would be anonymous. Furthermore, we told them, “if they do not want to continue the project, they can leave the project at each stage”.

3.3. Statistical Analysis

The data were analyzed by SPSS software (version 18) using the statistical data of 2%. In order to summarize the data, two - dimensional tables are used to show the number and the percent.

4. Results

In this study, 960 methamphetamine dependence were studied in order to evaluate the frequency of attention deficit hyperactivity disorder (ADHD). The demographic and clinical features of the methamphetamine dependence are shown in Table 1.

Table 1. Demographic and Clinical Features of Methamphetamine Dependence
Variable FrequencyPercent
Sex
Male75178.2
Female19420.00
Marital Status
Single38940.5
Married41643.5
Divorced10711.1
Widowed323.3
Unknown161.7
Education
Primary21121.10
Under diploma36738.2
Diploma and higher34936.4
Unknown333.4
Occupation
Jobless40742.4
Employed43749.27
Age group
12 - 20959.9
21 - 3034035.4
31 - 4028930.1
41 - 5015616.3
51 - 60363.8
61 - 7090.9
Unknown353.6
Disease pattern
Hyperactivity15561.1
Attention deficit40241.9
Hyper activity + Attention deficit14114.7
Unknown26227.3
Childhood ADHD
Yes28729.9
No67370.1
Table 2. Relationship Between Demographic Characteristics and Clinical Records of Methamphetamine Dependence with Childhood Attention Deficit Hyperactivity Disorder (ADHD)
Variable ADHD, No. (%)TotalK - Square StatisticSignificance Level
Yes ≥ 46No < 46
Sex55.71< 0.0001
Male266 (35.4)485 (64.6)751 (100)
Female15 (7.8)177 (92.2)192 (100)
Marital status56.27< 0.0001
Single110 (28.3)279 (71.7)389 (100)
Married162 (38.9)254 (61.1)416 (100)
Divorced8 (7.5)99 (92.5)107 (100)
Widowed0 (0.0)32 (100)32 (100)
Education26.41< 0.0001
Primary92 (43.6)119 (56.4)211 (100)
Under diploma91 (24.8)276 (75.2)367 (100)
Diploma and higher90 (25.8)259 (74.2)349 (100)
Occupation0.0120.485
Jobless121 (29.7)286 (70.3)407 (100)
Employed139 (29.4)334 (70.6)473 (100)
Age group54.79< 0.0001
15 - 207 (7.4)88 (92.6)95 (100)
21 - 3083 (24.4)257 (75.6)340 (100)
31 - 4097 (33.6)192 (66.4)289 (100)
41 - 5065 (41.7)91 (58.3)156 (100)
51 - 6019 (52.8)17 (47.2)36 (100)
61 - 706 (66.7)3 (33.3)9 (100)
Age of first Meth use0.4534.71
15 - 20105 (30.4)240 (69.6)345 (100)
21 - 2547 (23.4)154 (76.6)201 (100)
26 - 3045 (27.4)119 (72.6)164 (100)
31 - 3512 (21.1)45 (78.9)57 (100)
36 - 4017 (24.3)53 (75.7)70 (100)
> 409 (26.5)25 (73.5)34 (100)

There was a significant relationship between gender and prevalence of hyperactivity in childhood (P < 0.001), thus, the childhood hyperactivity in males was much higher than females. There was a significant relationship between marital status and hyperactivity in childhood (P < 0.001). The relationship between the levels of education and the prevalence of hyperactivity in childhood was significant, in the other word, those with a childhood hyperactivity were less successful in their educations. The results of the association showed that people who had a positive history of childhood hyperactivity took methamphetamine up to older ages. However, there was no significant statistical relationship between the prevalence of childhood hyperactivity and the onset of methamphetamine use (P = 0.453).

In addition, there was no significant relationship between the prevalence of childhood hyperactivity and occupational status (P = 0.484).

5. Discussion

In the current study, the comorbidity of attention deficit hyperactivity disorder (ADHD) with meth was studied. The prevalence of attention deficit hyperactivity disorder (ADHD) in adults and children in the drug-abuse population is estimated to be three times of the general population (23). Adults with a history of attention deficit hyperactivity disorder (ADHD) are exposed to more risk of substance use disorder than adults with no attention deficit hyperactivity disorder (24). Comorbidity of attention deficit hyperactivity disorder and drug abuse are associated with early onset, more severe period of drug - use disorder, weaker admission of treatment, very hard achievement to treatment goals, poor progression in treatment, and high rates of recurrence (25).

In the current study, the average age of meth abusers with ADHD is about 32.79 and average age of first meth abuse is 25.01. These findings are in line with studies conducted by Faraone et al., (26). Other research findings of the current study are that 35.4% of meth abusers who have ADHD are male and 78% are female. This finding is in line with study conducted by Biederman et al., (27-29).

Furthermore, there is significant difference between single subjects and married subjects in terms of ADHD. Approximately 38.9% of meth abusers who have ADHA are married and 61.1% of meth abusers are single, divorced, and widowed. This finding is not in line with the study of Sadeghi - Movahed (30). In regards to education, 38.2% of meth abusers with ADHS have an education lower than diploma and we cannot find a similar study in this respect. In the current study, we found out that 31% of meth abusers with ADHD are under 30 years old and this is in line with studies conducted by Wilens et al., (27).

Other findings of this research are that comorbidity between meth use and childhood ADHD disorder is 29.9%, this finding is in line with the study conducted by Biederman et al., (27, 28). Furthermore, this is in line with the research finding of Faraone et al., (26). The current study shows a relatively high prevalence of ADHD in the study population indicating a higher ratio than the study of Arabgol et al., (31). Wilens et al., shows that comorbidity between the drug use disorder and ADHD is strong (32).

With regard to the high prevalence of meth use and its increasing trend in the society, and according to the results of study in which the prevalence of childhood ADHA reaches high, we can say that ADHD can be seriously addressed as accompanying disorder with the meth abuse. If the ADHD is diagnosed in children very soon, it is possible to prevent them from meth abuse.

Regarding the high prevalence of psychiatric disorders in people taking meth in society, its financial costs, and its psychological consequences for the patients, their families, and the community, it is natural that the study of disorders in meth abusers is of great importance.

Some of the most important limitations of this research are (a) its cross - sectional nature, (b) the use of non - random and available samples, and (c) the possibility of unrealistic responses due to the use of self - report questionnaires.

The research findings of the current study can be used for treatment and prevention interventions. The results of the study have useful applications for therapists who work in the area of meth abuse treatment.

Acknowledgements

Footnotes

References

  • 1.

    Yarmohammadi-Vasel M, Farhoudian A, Farhadi MH, Tavakkoli M. [Therapeutic Community Effectiveness on Self-Esteem and Relapse Rate among Drug Users]. Arch Rehabil. 2012;13(1):114-20. Persian.

  • 2.

    Shariat SV, Elahi A. Symptoms and course of psychosis after methamphetamine abuse: one-year follow-up of a case. Prim Care Companion J Clin Psychiatry. 2010;12(5). doi: 10.4088/PCC.10l00959gry. [PubMed: 21274351]. [PubMed Central: PMC3026004].

  • 3.

    Alam-Mehrjerdi Z, Abdollahi M, Higgs P, Dolan K. Drug use treatment and harm reduction programs in Iran: A unique model of health in the most populated Persian Gulf country. Asian J Psychiatr. 2015;16:78-83. doi: 10.1016/j.ajp.2015.06.002. [PubMed: 26168763].

  • 4.

    Khajeamiri AR, Faizi M, Sohani F, Baheri T, Kobarfard F. Determination of impurities in illicit methamphetamine samples seized in Iran. Forensic Sci Int. 2012;217(1-3):204-6. doi: 10.1016/j.forsciint.2011.11.005. [PubMed: 22153622].

  • 5.

    Khazaie H, Jalali A, Jozani Y, Moradi S, Heydarpour F, Khaledi-Paveh B. Comparative study on sleep quality and disorders in opiate and methamphetamine users. Heroin Addict Relat Clin Probl. 2016;18(6):21-8.

  • 6.

    Hajebi A, Amini H, Kashani L, Sharifi V. Twelve-month course and outcome of methamphetamine-induced psychosis compared with first episode primary psychotic disorders. Early Interv Psychiatry. 2016. doi: 10.1111/eip.12404. [PubMed: 27991722].

  • 7.

    Farnia V, Shakeri J, Tatari F, Juibari TA, Bajoghli H, Golshani S, et al. Demographic and mental history-related data predicted occurrence of psychosis in metamphetamine users. Psychiatry Res. 2016;240:431-4. doi: 10.1016/j.psychres.2016.04.053. [PubMed: 27172885].

  • 8.

    Shakeri J, Farnia V, Karimi AR, Tatari F, Juibari TA, Alikhani M, et al. The prevalence and clinical features of amphetamine-induced obsessive compulsive disorder. Drug Alcohol Depend. 2016;160:157-62. doi: 10.1016/j.drugalcdep.2015.12.034. [PubMed: 26811120].

  • 9.

    Heydari ST, Vossoughi M, Akbarzadeh A, Lankarani KB, Sarikhani Y, Javanmardi K, et al. Prevalence and risk factors of alcohol and substance abuse among motorcycle drivers in Fars province, Iran. Chin J Traumatol. 2016;19(2):79-84. [PubMed: 27140214]. [PubMed Central: PMC4897829].

  • 10.

    Li P, Yu X, Xie J, Yao X, Liu W, Yao J, et al. Expression of cocaine- and amphetamine-regulated transcript (CART) in hen ovary. Biol Res. 2017;50(1):18. doi: 10.1186/s40659-017-0123-x. [PubMed: 28532517]. [PubMed Central: PMC5440929].

  • 11.

    Osland S, Hirsch L, Pringsheim T. Smoking, alcohol and drug use in youth and adults with attention-deficit hyperactivity disorder. BJPsych Open. 2017;3(3):141-6. doi: 10.1192/bjpo.bp.116.004317. [PubMed: 28546869]. [PubMed Central: PMC5437375].

  • 12.

    Haglund M, Ang A, Mooney L, Gonzales R, Chudzynski J, Cooper CB, et al. Predictors of depression outcomes among abstinent methamphetamine-dependent individuals exposed to an exercise intervention. Am J Addict. 2015;24(3):246-51. doi: 10.1111/ajad.12175. [PubMed: 25907813].

  • 13.

    Lugoboni F, Levin FR, Pieri MC, Manfredini M, Zamboni L, Somaini L, et al. Co-occurring Attention Deficit Hyperactivity Disorder symptoms in adults affected by heroin dependence: Patients characteristics and treatment needs. Psychiatry Res. 2017;250:210-6. doi: 10.1016/j.psychres.2017.01.052. [PubMed: 28473157]. [PubMed Central: PMC5518312].

  • 14.

    Egan TE, Dawson AE, Wymbs BT. Substance Use in Undergraduate Students With Histories of Attention-Deficit/Hyperactivity Disorder (ADHD): The Role of Impulsivity. Subst Use Misuse. 2017;52(10):1375-86. doi: 10.1080/10826084.2017.1281309. [PubMed: 28406351].

  • 15.

    Levin FR, Evans SM, Kleber HD. Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug Alcohol Depend. 1998;52(1):15-25. [PubMed: 9788002].

  • 16.

    Heiligenstein E, Guenther G, Levy A, Savino F, Fulwiler J. Psychological and academic functioning in college students with attention deficit hyperactivity disorder. J Am Coll Health. 1999;47(4):181-5. doi: 10.1080/07448489909595644. [PubMed: 9919849].

  • 17.

    Kessler RC, Adler LA, Barkley R, Biederman J, Conners CK, Faraone SV, et al. Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry. 2005;57(11):1442-51. doi: 10.1016/j.biopsych.2005.04.001. [PubMed: 15950019]. [PubMed Central: PMC2847347].

  • 18.

    Sadock BJ, Sadock VA. Synopsis of psychiatry. Philadelphia: Lippincott Williams and Wilkins; 2003.

  • 19.

    Ernst M, Grant SJ, London ED, Contoreggi CS, Kimes AS, Spurgeon L. Decision making in adolescents with behavior disorders and adults with substance abuse. Am J Psychiatry. 2003;160(1):33-40. doi: 10.1176/appi.ajp.160.1.33. [PubMed: 12505799].

  • 20.

    Durmus FB, Arman AR, Ayaz AB. Chronotype and its relationship with sleep disorders in children with attention deficit hyperactivity disorder. Chronobiol Int. 2017;34(7):886-94. doi: 10.1080/07420528.2017.1329207. [PubMed: 28574288].

  • 21.

    Reale L, Bartoli B, Cartabia M, Zanetti M, Costantino MA, Canevini MP, et al. Comorbidity prevalence and treatment outcome in children and adolescents with ADHD. Eur Child Adolesc Psychiatry. 2017;26(12):1443-57. doi: 10.1007/s00787-017-1005-z. [PubMed: 28527021].

  • 22.

    McCann BS, Scheele L, Ward N, Roy-Byrne P. Discriminant validity of the Wender Utah Rating Scale for attention-deficit/hyperactivity disorder in adults. J Neuropsychiatry Clin Neurosci. 2000;12(2):240-5. doi: 10.1176/jnp.12.2.240. [PubMed: 11001603].

  • 23.

    Mokhtari H, Rabiei M, Salimi SH. Psychometric properties of the persian version of adult attention-deficit/hyperactivity disorder self-report scale. Iran J Psychiatry Clin Psychol. 2015;21(3):244-53.

  • 24.

    Clure C, Brady KT, Saladin ME, Johnson D, Waid R, Rittenbury M. Attention-deficit/hyperactivity disorder and substance use: symptom pattern and drug choice. Am J Drug Alcohol Abuse. 1999;25(3):441-8. [PubMed: 10473007].

  • 25.

    Fischer M, Barkley RA, Smallish L, Fletcher K. Young adult follow-up of hyperactive children: self-reported psychiatric disorders, comorbidity, and the role of childhood conduct problems and teen CD. J Abnorm Child Psychol. 2002;30(5):463-75. [PubMed: 12403150].

  • 26.

    Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006;36(2):159-65. doi: 10.1017/S003329170500471X. [PubMed: 16420712].

  • 27.

    Biederman J, Wilens T, Mick E, Milberger S, Spencer TJ, Faraone SV. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry. 1995;152(11):1652-8. doi: 10.1176/ajp.152.11.1652. [PubMed: 7485630].

  • 28.

    Biederman J, Wilens TE, Mick E, Faraone SV, Spencer T. Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biol Psychiatry. 1998;44(4):269-73. [PubMed: 9715358].

  • 29.

    Biederman J, Wilens T, Mick E, Faraone SV, Weber W, Curtis S, et al. Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry. 1997;36(1):21-9. doi: 10.1097/00004583-199701000-00013. [PubMed: 9000777].

  • 30.

    Sadeghi Movahed F, Molavi P, Samadzadeh M, Shahbazzadegan B, Askari Moghadam R. [Prevalence of ADHD among the Students Residing in Dormitory of Ardabil University of Medical Sciences]. J Ardabil Univ Med Sci. 2012;12(5):87-94. Persian.

  • 31.

    Arabgol FHM, Hadid M. Prevalence of attention-deficit/hyperactivity disorder in a group of students. New Cogn Sci. 2004;6(1,2):73-8.

  • 32.

    Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics. 2003;111(1):179-85. [PubMed: 12509574].

  • Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
    COMMENTS

    LEAVE A COMMENT HERE: